Asia Pacific Pneumonia Testing Market By Method (Immunodiagnostics, Molecular Diagnostics, Point-Of-Care (POC) Testing), Type (Analyzers, Consumables), Technology (Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Western Blot, Polymerase Chain Reaction, Immunohistochemistry), End User (Hospitals, Diagnostic Centers, HomeCare), By Region, Industry Analysis and Forecast, 2020 - 2026

Analysis of Market Size & Trends

The Asia Pacific Pneumonia Testing Market would witness market growth of 11.2% CAGR during the forecast period (2020 - 2026). Pneumonia is a complicated infection affecting lower respiratory tract with symptoms such as short breathing, fever, chest pain, nausea, and vomiting. In the case of pneumonia, the air sacs of lungs called as alveoli, get filled with fluid or pus, causing inflammation. The condition is mainly caused due to microorganisms such as bacteria, virus, fungi, and parasites and affecting people with weak immune system. The case is quite common in children and older people. Based on WHO studies, pneumonia is one of the major causes of death among children and is estimated to affect approximately 1.2 million children under the age of five years, on an annual basis. As per WHO, 95% of all pneumococcal episodes occur in children in the developing countries. The demand for pain management drugs in the recent years is on the rise. POC testing is a revolutionary technology, which is now an ideal technique that is used in detecting pneumonia. The POC test can be carried out from the comfort of one’s home to bedside diagnosis in hospitals. Growing popularity for POC tests within the healthcare sector would add the market attractiveness during the forecast period.

Click Here For Free Insights:

Based on Method, the market is segmented into Point-Of-Care (POC) Testing, Immunodiagnostics and Molecular Diagnostics. Based on End User, the market is segmented into Diagnostic Centers, Hospitals, Homecare and Others. Based on type, the market is segmented into Analyzers and Consumables. Based on Technology, the market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence, Western Blot, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC) and Other Technology.. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.

Scope of the Study

Market Segmentation:

By Method

• Point-Of-Care (POC) Testing
• Immunodiagnostics
• Molecular Diagnostics

By End User

• Diagnostic Centers
• Hospitals
• Homecare
• Others

By Type

• Analyzers
• Consumables

By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Immunofluorescence
• Western Blot,
• Polymerase Chain Reaction (PCR)
• Immunohistochemistry (IHC)
• Other Technology.

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• Abbott Laboratories
• Becton, Dickinson and Company
• bioMérieux
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Hologic, Inc.
• Meridian Bioscience Inc.
• Quest Diagnostics Incorporated
• Quidel Corporation
• Thermo Fisher Scientific